Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Security class unavailable · CUSIP: H0036K147

Event date: 2020-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,011,215
Percent of class
5.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-019773
Form type
SC 13G
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Feb 10, 2021
Reporting period
May 11, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub